Company Filing History:
Years Active: 2020-2025
Title: Shanshan Song: Innovator in Pharmaceutical Chemistry
Introduction
Shanshan Song is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative research and development of novel compounds. With a total of 3 patents to her name, her work has garnered attention for its potential applications in medicine.
Latest Patents
Shanshan Song's latest patents include groundbreaking inventions that focus on triazolopyrimidine compounds and dihydroquinoxaline bromodomain recognition protein inhibitors. The first patent, titled "Triazolopyrimidine compound and salt, composition and use thereof," describes compounds that exhibit good activity and high selectivity for NAE. This innovation holds promise for various therapeutic applications. The second patent, "Dihydroquinoxaline bromodomain recognition protein inhibitor, preparation method and use thereof," details a compound that can inhibit bromodomain recognition proteins, potentially leading to new treatments for diseases mediated by these proteins.
Career Highlights
Shanshan Song is affiliated with the Chinese Academy of Sciences, where she conducts her research. Her work is characterized by a strong focus on developing compounds that can address significant medical challenges. Her innovative approach and dedication to research have positioned her as a key figure in her field.
Collaborations
Shanshan collaborates with esteemed colleagues, including Zehong Miao and Ao Zhang. These partnerships enhance her research efforts and contribute to the advancement of pharmaceutical sciences.
Conclusion
Shanshan Song's contributions to pharmaceutical chemistry through her patents and research are noteworthy. Her innovative work continues to pave the way for new medical advancements.